TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 3.73nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 3.90nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.20nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.20nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.30nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 4.90nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.20nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.30nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.40nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.40nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.70nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 5.90nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.10nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.20nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.20nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.70nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 6.90nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.10nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.10nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.10nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.18nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.30nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.30nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.40nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.40nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.5nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.60nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2 [790-1356](Homo sapiens (Human))
Crown Bioscience Inc. (Taiwan)
US Patent
Crown Bioscience Inc. (Taiwan)
US Patent
Affinity DataIC50: 7.80nMT: 2°CAssay Description:[Experimental method]: Use Lance@Ultra Ulight™-TK assay kit from PerKinElmer to evaluate the inhibitory activity of compounds at KDR kinase. [I...More data for this Ligand-Target Pair